 SAN DIEGO, July 29, 2021 GLOBE NEWSWIRE -- Oncternal Therapeutics, Inc. Nasdaq: ONCT, a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report second quarter 2021 financial results after the U.S. financial markets close on Thursday, August 5, 2021. Oncternals management will host a webcast at 2:00 p.m. PT 5:00 p.m. ET to provide a comprehensive business update and discuss the Companys financial results. 